Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases.
Fischer GM et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2025